Pathogens from the Gram-negative genus *Salmonella* infect around 1.3 billion people each year and are responsible for a spectrum of clinically significant human diseases ([@bib2]). Predominantly serovars of *S. enterica*, these pathogens can be loosely divided into two groups according to the type of disease they cause. Typhoidal serovars cause systemic illnesses such as typhoid fever, while nontyphoidal serovars cause localized gastroenteritis in otherwise healthy hosts ([@bib8]; [@bib12]).

Genes encoding cell surface structures are major loci of genetic variation between *Salmonella* serovars. These structures include lipopolysaccharides and flagellin, both of which are used in *Salmonella* serotyping ([@bib4]). Since our existing understanding of cell surface chemotypes does not fully explain the varied disease presentations caused by *Salmonella* serovars, it is reasonable to suggest that other cell wall lipids could have important roles to play in modulating the host response to *Salmonella*.
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For this reason, a team composed of scientists from the Netherlands, the US, Japan, and the UK sought to identify lipids that could be linked to the pathogenicity of certain serovars of *Salmonella*. To accomplish this, Reinink et al. took advantage of the comprehensive comparative lipidomics methodology developed by the Moody laboratory to study *Mycobacterium tuberculosis*, as shown in the figure ([@bib7]). By comparing the lipidome of the highly pathogenic serovar *S.* Typhi to that of the less pathogenic *S.* Paratyphi, the authors discovered a family of previously unknown trehalose phospholipids that were significantly enriched in *S.* Typhi. These lipids were conclusively identified as 6-phosphatidyltrehalose (PT) and 6,6′-diphosphatidyltrehalose (diPT) through a tour de force set of experiments, including extensive nontrivial mass spectrometry (MS), 1D and 2D nuclear magnetic resonance spectroscopy, and ultimately a nine-step chemical synthesis of diPT.
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The newly discovered trehalose phospholipids are chemically related to the important mycobacterial immunogen trehalose dimycolate (TDM), or cord factor ([@bib1]). This similarity prompted [@bib11] to investigate the potential immunogenicity of trehalose phospholipids, specifically the ability of diPT to stimulate the Mincle receptor. Mincle, a myeloid cell C-type lectin pattern recognition receptor, is essential for the TDM-dependent inflammatory response ([@bib6]). Using reporter cell lines expressing Mincle and its signaling partner FcRγ, the authors confirmed that Mincle recognizes diPT in a dose-dependent manner.

Next, [@bib11] investigated how trehalose phospholipids are synthesized in *Salmonella*. By considering PT and diPT as carbohydrate-substituted phosphatidylglycerols, bioinformatic analysis identified 12 genes that are potentially involved in the biosynthesis of these molecules. A systematic gene knockout experiment indicated that only one of these genes, *clsB*, was essential for trehalose phospholipid biosynthesis. Consequently, the authors propose that *clsB*, which was previously annotated as one of three cardiolipin synthases in *Salmonella*, is in fact a PT and diPT synthase.

This result highlights a major obstacle to understanding infection biology, namely the poor annotation of bacterial genomes and their metabolic products. In the era of high-throughput genome sequencing, functional annotation relies heavily on automated procedures, with the manually curated SwissProt database now comprising just 0.63% of the UniProt Knowledgebase ([@bib5]). However, automated annotation pipelines are vulnerable to errors such as over-annotation. These errors propagate through sequence databases and can be difficult to identify and correct ([@bib3]).

Accurate annotation of multigene families (where multiple family members are present in the same genome) is particularly challenging since the enzymes in these families often undertake similar chemistry on closely related substrates ([@bib13]). With this in mind, it is perhaps unsurprising that the trehalose phospholipid synthase identified by [@bib11] was originally annotated as a cardiolipin synthase. Nonetheless, the observation that *S.* Typhi *clsB* does not appear to encode a cardiolipin synthase should prompt a thorough analysis of the genes annotated as such, since this aspect of lipid biosynthesis is evidently more nuanced than its annotations suggest. Further experiments are clearly required to facilitate the unambiguous assignment of homologues of cardiolipin synthases in bacterial genomes, for example activity-based metabolomic profiling of recombinant enzymes or global metabolomic profiling of deletion mutants ([@bib9]; [@bib10]).

Having identified that trehalose phospholipids are differentially expressed between *Salmonella* serovars, the authors evaluated whether PT and diPT are synthesized by other bacterial species possessing *clsB* orthologues. Of the species chemotyped, only *Escherichia coli* produced these compounds, and then only in four of the six strains tested. As noted by [@bib11], further studies will be required to identify whether this is due to differences in *clsB* expression, enzyme functionality, or interactions with other enzymes.

Bacterial gene expression and cell wall composition can be extensively altered on host colonization. It would therefore be of interest to determine whether PT and diPT are core lipids in *Salmonella* or whether their levels change in response to the host environment. Future experiments should also seek to identify if receptors other than Mincle are involved in sensing trehalose-containing lipids. This would assist in the elucidation of the downstream effects of these molecules on the immune system and the organism as a whole, information that will be essential for a complete understanding of the role of trehalose phospholipids in host--pathogen interactions and infection.

Finally, the comparative lipidomics experiment identified hundreds of other statistically significant differences between the *S.* Typhi and *S.* Paratyphi lipidomes. Characterization of these hits, which will require the development of novel high-throughput approaches, will dramatically expand our understanding of cell envelope structure and function in *S.* Typhi.

In conclusion, the study by [@bib11] highlights a quintessential fact: the vast majority of metabolites in bacteria remain to be discovered and structurally characterized, and a significant number of biosynthetic pathways have therefore yet to be elucidated. Several of these complex metabolites will exert important effects on the host and other bacteria and will consequently have translational applications.
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